203 related articles for article (PubMed ID: 30227322)
1. Bergapten inhibits liver carcinogenesis by modulating LXR/PI3K/Akt and IDOL/LDLR pathways.
Pattanayak SP; Bose P; Sunita P; Siddique MUM; Lapenna A
Biomed Pharmacother; 2018 Dec; 108():297-308. PubMed ID: 30227322
[TBL] [Abstract][Full Text] [Related]
2. Taxifolin binds with LXR (α & β) to attenuate DMBA-induced mammary carcinogenesis through mTOR/Maf-1/PTEN pathway.
Haque MW; Bose P; Siddique MUM; Sunita P; Lapenna A; Pattanayak SP
Biomed Pharmacother; 2018 Sep; 105():27-36. PubMed ID: 29843042
[TBL] [Abstract][Full Text] [Related]
3. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
4. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.
Guo D; Reinitz F; Youssef M; Hong C; Nathanson D; Akhavan D; Kuga D; Amzajerdi AN; Soto H; Zhu S; Babic I; Tanaka K; Dang J; Iwanami A; Gini B; Dejesus J; Lisiero DD; Huang TT; Prins RM; Wen PY; Robins HI; Prados MD; Deangelis LM; Mellinghoff IK; Mehta MP; James CD; Chakravarti A; Cloughesy TF; Tontonoz P; Mischel PS
Cancer Discov; 2011 Oct; 1(5):442-56. PubMed ID: 22059152
[TBL] [Abstract][Full Text] [Related]
5. The LXR-IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradation.
Sorrentino V; Nelson JK; Maspero E; Marques ARA; Scheer L; Polo S; Zelcer N
J Lipid Res; 2013 Aug; 54(8):2174-2184. PubMed ID: 23733886
[TBL] [Abstract][Full Text] [Related]
6. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
[TBL] [Abstract][Full Text] [Related]
7. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.
Zelcer N; Hong C; Boyadjian R; Tontonoz P
Science; 2009 Jul; 325(5936):100-4. PubMed ID: 19520913
[TBL] [Abstract][Full Text] [Related]
8. Involvement of NF-κB/PI3K/AKT signaling pathway in the protective effect of prunetin against a diethylnitrosamine induced hepatocellular carcinogenesis in rats.
Li G; Qi L; Chen H; Tian G
J Biochem Mol Toxicol; 2022 May; 36(5):e23016. PubMed ID: 35239232
[TBL] [Abstract][Full Text] [Related]
9. Regulation of intestinal LDLR by the LXR-IDOL axis.
van Loon NM; van Wouw SAE; Ottenhoff R; Nelson JK; Kingma J; Scheij S; Moeton M; Zelcer N
Atherosclerosis; 2020 Dec; 315():1-9. PubMed ID: 33190106
[TBL] [Abstract][Full Text] [Related]
10. Garlic Oil Suppressed Nitrosodiethylamine-Induced Hepatocarcinoma in Rats by Inhibiting PI3K-AKT-NF-κB Pathway.
Zhang CL; Zeng T; Zhao XL; Xie KQ
Int J Biol Sci; 2015; 11(6):643-51. PubMed ID: 25999787
[TBL] [Abstract][Full Text] [Related]
11. The LXR-Idol axis differentially regulates plasma LDL levels in primates and mice.
Hong C; Marshall SM; McDaniel AL; Graham M; Layne JD; Cai L; Scotti E; Boyadjian R; Kim J; Chamberlain BT; Tangirala RK; Jung ME; Fong L; Lee R; Young SG; Temel RE; Tontonoz P
Cell Metab; 2014 Nov; 20(5):910-918. PubMed ID: 25440061
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K/Akt/mTOR signaling pathway.
Wang SS; Chen YH; Chen N; Wang LJ; Chen DX; Weng HL; Dooley S; Ding HG
Cell Death Dis; 2017 Mar; 8(3):e2688. PubMed ID: 28333142
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.
Li Y; Ye Y; Feng B; Qi Y
J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252
[TBL] [Abstract][Full Text] [Related]
14. β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling.
Yang Y; Guo Y; Tan S; Ke B; Tao J; Liu H; Jiang J; Chen J; Chen G; Wu B
Nat Commun; 2015 Jun; 6():7369. PubMed ID: 26077142
[TBL] [Abstract][Full Text] [Related]
15. Phyllanthin prevents diethylnitrosamine (DEN) induced liver carcinogenesis in rats and induces apoptotic cell death in HepG2 cells.
You Y; Zhu F; Li Z; Zhang L; Xie Y; Chinnathambi A; Alahmadi TA; Lu B
Biomed Pharmacother; 2021 May; 137():111335. PubMed ID: 33581648
[TBL] [Abstract][Full Text] [Related]
16. Involvement of PI3K/Akt pathway in the inhibition of hepatocarcinoma cell invasion and metastasis induced by SASH1 through downregulating Shh-Gli1 signaling.
Sun C; Zhang Z; He P; Zhou Y; Xie X
Int J Biochem Cell Biol; 2017 Aug; 89():95-100. PubMed ID: 28600143
[TBL] [Abstract][Full Text] [Related]
17. LAMP3 regulates hepatic lipid metabolism through activating PI3K/Akt pathway.
Liao X; Song L; Zhang L; Wang H; Tong Q; Xu J; Yang G; Yang S; Zheng H
Mol Cell Endocrinol; 2018 Jul; 470():160-167. PubMed ID: 29056532
[TBL] [Abstract][Full Text] [Related]
18. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.
Liu S; Zhang W; Liu K; Ji B; Wang G
Mol Med Rep; 2015 Jan; 11(1):597-602. PubMed ID: 25323956
[TBL] [Abstract][Full Text] [Related]
19. Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis.
Zhang L; Reue K; Fong LG; Young SG; Tontonoz P
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2541-6. PubMed ID: 22936343
[TBL] [Abstract][Full Text] [Related]
20. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.
Cui SX; Shi WN; Song ZY; Wang SQ; Yu XF; Gao ZH; Qu XJ
Oncotarget; 2016 Jun; 7(24):36767-36782. PubMed ID: 27167344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
